These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients. Zhao Y; Zhao Z; Shen H; Bing Q; Hu J Neurol Sci; 2018 Dec; 39(12):2043-2051. PubMed ID: 30232666 [TBL] [Abstract][Full Text] [Related]
10. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations. Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2. Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877 [TBL] [Abstract][Full Text] [Related]
12. DNM2 mutations in Chinese Han patients with centronuclear myopathy. Lin P; Liu X; Zhao D; Dai T; Wu H; Gong Y; Yan C Neurol Sci; 2016 Jun; 37(6):995-8. PubMed ID: 26908122 [TBL] [Abstract][Full Text] [Related]
13. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation. Liewluck T; Lovell TL; Bite AV; Engel AG Neuromuscul Disord; 2010 Dec; 20(12):801-4. PubMed ID: 20817456 [TBL] [Abstract][Full Text] [Related]
14. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves. Tinelli E; Pereira JA; Suter U Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975 [TBL] [Abstract][Full Text] [Related]
15. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies. Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630 [TBL] [Abstract][Full Text] [Related]
16. Satellite cells deficiency and defective regeneration in dynamin 2-related centronuclear myopathy. F Almeida C; Bitoun M; Vainzof M FASEB J; 2021 Apr; 35(4):e21346. PubMed ID: 33715228 [TBL] [Abstract][Full Text] [Related]
17. Centronuclear myopathies: a widening concept. Romero NB Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480 [TBL] [Abstract][Full Text] [Related]
18. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation. Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552 [TBL] [Abstract][Full Text] [Related]
19. Mice with muscle-specific deletion of Bin1 recapitulate centronuclear myopathy and acute downregulation of dynamin 2 improves their phenotypes. Silva-Rojas R; Nattarayan V; Jaque-Fernandez F; Gomez-Oca R; Menuet A; Reiss D; Goret M; Messaddeq N; Lionello VM; Kretz C; Cowling BS; Jacquemond V; Laporte J Mol Ther; 2022 Feb; 30(2):868-880. PubMed ID: 34371181 [TBL] [Abstract][Full Text] [Related]